Bladder and kidney cancer following cyclophosphamide therapy for non-Hodgkin's lymphoma.

Travis, L B; Curtis, R E; Glimelius, B; Holowaty, E J; Van Leeuwen, F E; Lynch, C F; Hagenbeek, A; Stovall, M; Banks, P M; Adami, J

Travis, L B; Curtis, R E; Glimelius, B; Holowaty, E J; Van Leeuwen, F E; Lynch, C F; Hagenbeek, A; Stovall, M; Banks, P M; Adami, J.

Affiliation

Travis LB; Epidemiology and Biostatistics Program, National Cancer Institute, Bethesda, Md, USA.

J Natl Cancer Inst ; 87(7): 524-30, 1995 Apr 05.

Article in En | MEDLINE | ID: mdl-7707439

Subject(s)

Cyclophosphamide/adverse effects; Kidney Neoplasms/chemically induced; Lymphoma, Non-Hodgkin/drug therapy; Neoplasms, Second Primary/chemically induced; Urinary Bladder Neoplasms/chemically induced; Aged; Case-Control Studies; Cyclophosphamide/administration & dosage; Cyclophosphamide/therapeutic use; Dose-Response Relationship, Drug; Female; Follow-Up Studies; Humans; Male; Middle Aged; Radiotherapy, Adjuvant

Search on Google

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Urinary Bladder Neoplasms / Lymphoma, Non-Hodgkin / Neoplasms, Second Primary / Cyclophosphamide / Kidney Neoplasms Type of study: Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Aged / Female / Humans / Male / Middle aged Language: En Journal: J Natl Cancer Inst Year: 1995 Type: Article Affiliation country: United States

Search on Google

XML

PubMed Links